3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Advanced Breast Cancer
1
Interventions
Cyclophosphamide
9
glofitamab
4
Whole-Body Irradiation
4
Rituximab
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Ritonavir
×
1 year
×
Clear all
No trials found.